Form 4: Pediatrix Medical Group Executive Transfers Shares to Family Trust

Sentiment:

SEC Form 4 Filing


Mary Ann E. Moore, EVP, GC, Chief Admin Off & Sec of Pediatrix Medical Group, transferred 26,497 shares of common stock to a family trust on March 6, 2025.

Summary

  • On March 6, 2025, Mary Ann E. Moore, an executive at Pediatrix Medical Group, transferred 26,497 shares of common stock to a trust.
  • Moore and her spouse are trustees of the trust, and her immediate family members are the beneficiaries.
  • Following the transaction, Moore directly owns 100,338 shares of common stock.
  • Moore also indirectly owns 42,227 shares through the trust.
  • Moore disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a share transfer. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions and provides transparency into the holdings of company executives. It doesn't necessarily reflect broader industry trends but is important for investors monitoring insider activity.

Related Party Transactions

  • The transfer of shares to a trust where immediate family members are beneficiaries constitutes a related party transaction.

Stakeholder Impact

  • The transaction itself is unlikely to have a significant impact on stakeholders.
  • However, transparency in insider transactions is important for maintaining investor confidence.

Key Dates

DateDescription
03/06/2025Date of the share transfer to the trust
03/07/2025Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.